Arcutis BiotherapeuticsARQT
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 272 institutions reported holding Arcutis Biotherapeutics Inc. (ARQT) in their 13F filings, up 2 from Q1 2026. 38 opened new positions and 36 sold out. The largest holders were Montanova Capital, LLC ($326.1M), BlackRock, Inc. ($276.5M) and Frazier Life Sciences Management, L.P. ($258.9M). 9 famous investors held it, including David E. Shaw (0.1% of D. E. Shaw & Co.'s portfolio), Ron Baron (0.0% of Baron Capital (BAMCO)'s portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Arcutis Biotherapeutics Inc.
- CUSIP
- 03969K108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 38 | $129.1M |
| Exits | 36 | $63.4M |
All 13F filers, Q1 2026 → Q2 2026: 16,525,270 shares bought and 17,393,532 shares sold, net −868,262 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 272 holders
| Montanova Capital, LLC | 6.85% | Add +0.9% | 12,437,000 | $326.1M |
| BlackRock, Inc. | 0.00% | Add +14.6% | 10,545,466 | $276.5M |
| Frazier Life Sciences Management, L.P. | 5.65% | No change | 9,874,511 | $258.9M |
| Rubric Capital Management LP | 1.99% | No change | 8,271,577 | $216.9M |
| Polar Capital Holdings Plc | 0.49% | Add +16.6% | 6,606,945 | $173.2M |
| State Street Corp. | 0.00% | Reduce -7.5% | 5,822,840 | $152.7M |
| Vanguard Capital Management LLC | 0.00% | Add +2.4% | 4,988,756 | $130.8M |
| Morgan Stanley | 0.01% | Add +5.5% | 4,451,014 | $116.7M |
| Jennison Associates LLC | 0.07% | Reduce -15.3% | 4,219,058 | $110.6M |
| D. E. Shaw & Co. | 0.07% | Add +58.2% | 3,949,609 | $103.6M |
| UBS Group AG | 0.01% | Add +0.1% | 3,333,015 | $87.4M |
| Bank of America Corp. | 0.01% | Add +34.5% | 2,987,431 | $78.3M |
| Geode Capital Management, LLC | 0.00% | Reduce -2.1% | 2,982,446 | $78.2M |
| Vanguard Portfolio Management LLC | 0.00% | Add +24.3% | 2,429,005 | $63.7M |
| Orbimed Advisors LLC | 1.02% | New | 2,042,000 | $53.5M |
| Franklin Resources Inc. | 0.01% | Reduce -16.0% | 1,930,982 | $50.6M |
| American Century Companies Inc. | 0.02% | Add +31.6% | 1,925,031 | $50.5M |
| Goldman Sachs Group Inc. | 0.00% | Add +4.1% | 1,668,367 | $43.7M |
| Jupiter Topco LLC | 0.02% | — | 1,410,435 | $37.0M |
| Oberweis Asset Management Inc./ | 0.74% | Add +0.5% | 1,372,941 | $36.0M |
| Gilder Gagnon Howe & Co. LLC | 0.36% | Reduce -69.5% | 1,313,211 | $34.4M |
| GW&K Investment Management, LLC | 0.26% | Add +30.3% | 1,288,018 | $33.8M |
| Pivotal bioVenture Partners Investment Advisor LLC | 10.78% | Reduce -6.7% | 1,265,283 | $33.2M |
| Baron Capital (BAMCO) | 0.05% | Add +16.9% | 1,253,120 | $32.9M |
| Citadel Advisors | 0.02% | Add +7333.1% | 1,160,014 | $30.4M |
| Federated Hermes, Inc. | 0.04% | Add +4.4% | 1,124,629 | $29.5M |
| Perpetual Ltd | 0.42% | Add +22.0% | 1,109,657 | $29.1M |
| Aberdeen Group plc | 0.04% | Add +70.3% | 1,098,411 | $28.8M |
| Jones Hill Capital LP | 6.07% | New | 1,089,701 | $28.6M |
| Northern Trust Corp. | 0.00% | Add +8.4% | 1,058,575 | $27.8M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +3.8% | 1,050,934 | $27.6M |
| Ensign Peak Advisors, Inc | 0.04% | Reduce -21.7% | 974,534 | $25.6M |
| Candriam S.C.A. | 0.11% | Reduce -12.6% | 949,839 | $24.9M |
| Driehaus Capital Management LLC | 0.13% | Reduce -60.5% | 878,426 | $23.0M |
| Nuveen, LLC | 0.01% | Reduce -7.5% | 834,261 | $21.9M |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +5.6% | 815,138 | $21.4M |
| Manufacturers Life Insurance Company, The | 0.02% | Add +61.1% | 811,752 | $21.3M |
| Two Sigma Investments, LP | 0.01% | Add +183.3% | 663,877 | $17.4M |
| Fishman Jay A Ltd. | 1.24% | Add +5.0% | 595,005 | $15.6M |
| Millennium Management | 0.01% | Add +1043.4% | 564,072 | $14.8M |
| BNP Paribas Financial Markets | 0.01% | Reduce -32.6% | 547,278 | $14.3M |
| Squarepoint Ops LLC | 0.03% | Reduce -51.3% | 537,747 | $14.1M |
| Capitolis Liquid Global Markets LLC | 0.06% | No change | 500,000 | $13.1M |
| Nearwater Capital Markets, Ltd | 0.22% | Reduce -19.9% | 486,700 | $12.8M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | Add +27.3% | 466,000 | $12.2M |
| Marshall Wace, LLP | 0.01% | Reduce -81.6% | 446,866 | $11.7M |
| Privium Fund Management B.V. | 1.92% | Add +24.4% | 399,367 | $10.5M |
| Norges Bank | 0.00% | — | 392,300 | $10.3M |
| Deutsche Bank AG | 0.00% | Reduce -1.8% | 382,682 | $10.0M |
| Patient Square Capital LP | 1.50% | Reduce -7.7% | 370,000 | $9.7M |
| Point72 Asset Management | 0.02% | Reduce -38.7% | 362,449 | $9.5M |
| Qube Research & Technologies Ltd | 0.01% | Reduce -50.0% | 361,662 | $9.5M |
| Longaeva Partners L.P. | 0.26% | New | 344,796 | $9.0M |
| AQR Capital Management | 0.00% | Reduce -29.5% | 330,324 | $8.7M |
| Bank of New York Mellon Corp | 0.00% | Add +8.0% | 330,094 | $8.7M |
| FMR LLC | 0.00% | Add +9.8% | 305,969 | $8.0M |
| Ameriprise Financial Inc. | 0.00% | Add +191.1% | 295,997 | $7.8M |
| Peregrine Capital Management LLC | 0.25% | Reduce -4.8% | 291,447 | $7.6M |
| Healthcare of Ontario Pension Plan Trust Fund | 0.01% | Reduce -55.2% | 284,789 | $7.5M |
| First Trust Advisors LP | 0.00% | Reduce -19.1% | 284,065 | $7.4M |
| Invesco Ltd. | 0.00% | Add +89.4% | 264,907 | $6.9M |
| Walleye Capital LLC | 0.04% | Add +415.3% | 260,033 | $6.8M |
| Balyasny Asset Management L.P. | 0.01% | New | 243,119 | $6.4M |
| PFM Health Sciences, LP | 0.55% | New | 242,069 | $6.3M |
| MYDA Advisors LLC | 1.54% | No change | 240,000 | $6.3M |
| Jump Financial, LLC | 0.06% | Add +375.1% | 235,471 | $6.2M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Reduce -2.5% | 231,186 | $6.1M |
| State of Wisconsin Investment Board | 0.01% | Add +128.8% | 230,905 | $6.1M |
| Swiss National Bank | 0.00% | Add +2.7% | 224,000 | $5.9M |
| Susquehanna International Group, LLP | 0.01% | Add +96.0% | 219,815 | $5.8M |
| Pictet Asset Management Holding SA | 0.01% | Add +45.0% | 200,275 | $5.4M |
| Jupiter Asset Management Ltd. | 0.03% | Reduce -6.8% | 202,515 | $5.3M |
| Kornitzer Capital Management Inc. | 0.11% | Add +13.5% | 199,683 | $5.2M |
| Woodline Partners LP | 0.02% | No change | 195,033 | $5.1M |
| Pavaki Capital Management LLC | 2.79% | No change | 187,000 | $4.9M |
| Principal Financial Group Inc. | 0.00% | Add +8.8% | 183,662 | $4.8M |
| Cormorant Asset Management, LP | 0.24% | Reduce -61.1% | 175,000 | $4.6M |
| Rhumbline Advisers | 0.00% | Add +5.8% | 170,542 | $4.5M |
| Holocene Advisors, LP | 0.01% | New | 163,732 | $4.3M |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -64.8% | 157,778 | $4.1M |
| Voloridge Investment Management, LLC | 0.02% | Reduce -70.9% | 157,429 | $4.1M |
| PDT Partners, LLC | 0.21% | No change | 155,075 | $4.1M |
| Vontobel Holding Ltd. | 0.01% | Add +342.8% | 153,242 | $4.0M |
| Citigroup Inc. | 0.00% | Add +213.2% | 151,394 | $4.0M |
| Los Angeles Capital Management LLC | 0.01% | Reduce -10.7% | 137,929 | $3.6M |
| Essex Investment Management Co. LLC | 0.47% | Reduce -4.5% | 137,500 | $3.6M |
| Castleark Management LLC | 0.10% | Reduce -53.2% | 137,420 | $3.6M |
| Eversept Partners, LP | 0.19% | Reduce -76.5% | 135,355 | $3.5M |
| Lazard Asset Management LLC | 0.01% | Reduce -13.9% | 133,146 | $3.5M |
| Tudor Investment Corporation | 0.01% | New | 131,914 | $3.5M |
| California State Teachers Retirement System | 0.00% | Reduce -1.6% | 126,258 | $3.3M |
| Alliancebernstein L.P. | 0.00% | Add +15.4% | 136,393 | $3.2M |
| 1492 Capital Management LLC | 0.90% | Reduce -1.6% | 116,211 | $3.0M |
| Sei Investments Co. | 0.00% | Reduce -44.6% | 114,253 | $3.0M |
| Tejara Capital Ltd | 1.22% | Reduce -32.0% | 113,084 | $3.0M |
| LPL Financial LLC | 0.00% | Reduce -6.9% | 111,150 | $2.9M |
| Wells Fargo & Company | 0.00% | Reduce -44.9% | 109,079 | $2.9M |
| Schroder Investment Management Group | 0.00% | No change | 104,356 | $2.8M |
| JPMorgan Chase & Co. | 0.00% | Reduce -13.3% | 97,966 | $2.8M |
| Legal & General Group Plc | 0.00% | Add +18.8% | 100,808 | $2.6M |
"% of holder's portfolio" is ARQT's weight in each manager's 13F, not the share of Arcutis Biotherapeutics Inc. the manager owns.